Jenny is a versatile life sciences patent attorney and IP adviser who represents US and international clients in a wide array of patent-related matters. She draws on an in-depth understanding of her clients’ industries and technology to help them protect innovations involving antibodies, cell therapies, gene editing, small molecule therapeutics, pharmaceutical formulations, and diagnostic agents and assays.

Jenny’s practice encompasses US and international patent prosecution, IP due diligence for transactions, clearance analyses, licensing, opinion work, and post-grant proceedings. She has extensive experience with providing strategic counseling on the life-cycle management of both biological and small molecule products.

Prior to joining Mintz, Jenny practiced patent law for more than 15 years, most recently as a partner at an international law firm. Earlier in her career, as a Harvard Medical School postdoctoral fellow, she worked in the laboratory of Dr. David Hafler at Brigham & Women’s Hospital. In that role, she conducted research on T cell activity in autoimmune diseases such as Type 1 diabetes.